Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Atara Biotherapeutics
Atara Biotherapeutics
Becton, Dickinson and Company
Sesen Bio, Inc.
Cedars-Sinai Medical Center
Assistance Publique - HĂ´pitaux de Paris
Assistance Publique - HĂ´pitaux de Paris
Abbott